May 31, 2000 |
The term medical
marijuana took on dramatic new meaning in February, 2000 when
researchers in Madrid announced they had destroyed incurable brain
tumors in rats by injecting them with THC, the active ingredient in
cannabis.
The Madrid study marks
only the second time that THC has been administered to tumor-bearing
animals; the first was a Virginia investigation 26 years ago. In both
studies, the THC shrank or destroyed tumors in a majority of the test
subjects.
Most Americans don't
know anything about the Madrid discovery. Virtually no major U.S.
newspapers carried the story, which ran only once on the AP and UPI news
wires, on Feb. 29, 2000.
The
ominous part is that this isn't the first time scientists have
discovered that THC shrinks tumors. In 1974 researchers at the Medical
College of Virginia, who had been funded by the National Institute of
Health to find evidence that marijuana damages the immune system, found
instead that THC slowed the growth of three kinds of cancer in mice --
lung and breast cancer, and a virus-induced leukemia.
The
DEA quickly shut down the Virginia study and all further cannabis/tumor
research, according to Jack Herer, who reports on the events in his
book, "The Emperor Wears No Clothes." In 1976 President Gerald Ford put
an end to all public cannabis research and granted exclusive research
rights to major pharmaceutical companies, who set out -- unsuccessfully
-- to develop synthetic forms of THC that would deliver all the medical
benefits without the "high."
The
Madrid researchers reported in the March issue of "Nature Medicine"
that they injected the brains of 45 rats with cancer cells, producing
tumors whose presence they confirmed through magnetic resonance imaging
(MRI).
On the 12th day they injected 15 of the rats with THC and 15 with
Win-55,212-2 a synthetic compound similar to THC. "All the rats left
untreated uniformly died 12-18 days after glioma (brain cancer) cell
inoculation ... Cannabinoid (THC)-treated rats survived significantly
longer than control rats. THC administration was ineffective in three
rats, which died by days 16-18. Nine of the THC-treated rats surpassed
the time of death of untreated rats, and survived up to 19-35 days.
Moreover, the tumor was completely eradicated in three of the treated
rats." The rats treated with Win-55,212-2 showed similar results.
The
Spanish researchers, led by Dr. Manuel Guzman of Complutense
University, also irrigated healthy rats' brains with large doses of THC
for seven days, to test for harmful biochemical or neurological effects.
They found none.
"Careful MRI
analysis of all those tumor-free rats showed no sign of damage related
to necrosis, edema, infection or trauma ... We also examined other
potential side effects of cannabinoid administration. In both tumor-free
and tumor-bearing rats, cannabinoid administration induced no
substantial change in behavioral parameters such as motor coordination
or physical activity. Food and water intake as well as body weight gain
were unaffected during and after cannabinoid delivery. Likewise, the
general hematological profiles of cannabinoid-treated rats were normal.
Thus, neither biochemical parameters nor markers of tissue damage
changed substantially during the 7-day delivery period or for at least 2
months after cannabinoid treatment ended."
Guzman's
investigation is the only time since the 1974 Virginia study that THC
has been administered to live tumor-bearing animals. (The Spanish
researchers cite a 1998 study in which cannabinoids inhibited breast
cancer cell proliferation, but that was a "petri dish" experiment that
didn't involve live subjects.)
In
an email interview for this story, the Madrid researcher said he had
heard of the Virginia study, but had never been able to locate
literature on it. Hence, the Nature Medicine article characterizes the
new study as the first on tumor-laden animals and doesn't cite the 1974
Virginia investigation.
Loading
|
Marijuana Health Studies Universities Around the Globe Indexed Here for Easy Reference |
No comments:
Post a Comment